Use of doxorubicin plus cyclophosphamide followed by docetaxel as adjuvant chemotherapy for beast cancer

L. Livi, I. Meattini, C. de Luca Cardillo, V. Scotti, B. Agresti, C. Franzese, L. Sanchez, J. Nori, S. Bertocci, S. Cassani, S. Bianchi, L. Cataliotti, G. Biti

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Use of doxorubicin plus cyclophosphamide followed by docetaxel as adjuvant chemotherapy for beast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences